Related Experiment Video

Updated: Dec 2, 2025

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

3.2K

Key populations for early COVID-19 immunization: preliminary guidance for policy

Shainoor J Ismail1, Linlu Zhao1, Matthew C Tunis1

  • 1Centre for Immunization and Respiratory Infectious Diseases (Ismail, Zhao, Tunis), Public Health Agency of Canada, Ottawa, Ont.; Metro City Medical Clinic (Ismail), Edmonton, Alta.; Public Health Ontario (Deeks); Dalla Lana School of Public Health (Deeks), University of Toronto, Toronto, Ont.; Department of Microbiology, Infectious Diseases & Immunology (Quach), University of Montreal; Department of Clinical Laboratory Medicine (Quach), CHU Sainte-Justine, Montréal, Que.

CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|November 4, 2020
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers06:34

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

37.4K
Experimental Human Pneumococcal Carriage07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

16.0K

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
49.8K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
601
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.7K